Frazier Life Sciences Management, L.P.

Position in BCRX — Biocryst Pharmaceuticals Inc

CIK 1892134 PALO ALTO, CA

Back to BCRX Full portfolio

Position in BCRX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$40,092,400

+$1,924,436 QoQ

Shares Held

4,009,240

0.0% QoQ

Ownership

1.57%

of shares outstanding

% of Portfolio

0.87%

of 13F equity value

Holder Rank

#17

of 316 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in BCRX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Frazier Life Sciences Management, L.P. holds $95,063,117 across 3 Drug Manufacturers - Specialty & Generic names. BCRX ranks #1 (42.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BCRX	Biocryst Pharmaceuticals Inc This page	4,009,240	$40,092,400
2	ALKS	Alkermes plc.	700,647	$36,713,902
3	EOLS	Evolus, Inc.	2,630,665	$18,256,815

All Filings in BCRX

Export CSV

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$40,092,400	4,009,240	0.0%	Shares	Sole	2026-08-14
2026-03-31	$38,167,964	4,009,240	—	Shares	Sole	2026-05-15
No filing history on record for this holder in this stock.